Wedbush Maintains Neutral on Voyager Therapeutics, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Laura Chico maintains a Neutral rating on Voyager Therapeutics (NASDAQ:VYGR) and lowers the price target from $8 to $7.
August 07, 2024 | 1:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Wedbush analyst Laura Chico maintains a Neutral rating on Voyager Therapeutics and lowers the price target from $8 to $7.
The lowered price target from $8 to $7 by a reputable analyst suggests a less optimistic outlook for Voyager Therapeutics, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100